The spectrum of IgG GQ1(b) syndrome: an unusual cluster

M H Williams1

  • 1Department of Medicine, Gold Coast Hospital, Queensland, Australia.

Insights

A rare cluster of GQ1b antibody syndrome occurred over four months, showcasing its diverse clinical presentations. This includes mild Miller Fisher Syndrome and severe Bickerstaff

Area of Science:

  • Neurology
  • Immunology

Background:

  • GQ1b antibodies are associated with specific neurological disorders.
  • Miller Fisher Syndrome (MFS) and Bickerstaff's brainstem encephalitis (BBE) are rare conditions.

Observation:

  • An unusual cluster of four patients with IgG GQ1b antibodies presented within a four-month period.
  • The cases were admitted to a single public hospital serving approximately 400,000 people.

Findings:

  • The observed cases demonstrated the wide spectrum of GQ1b antibody-associated disorders.
  • Presentations ranged from benign ophthalmoplegia, ataxia, and areflexia (MFS) to severe encephalitis (BBE).

Implications:

  • This cluster suggests potential environmental or unknown triggers for GQ1b antibody syndrome.
  • Understanding the spectrum is crucial for accurate diagnosis and management of these rare neurological conditions.

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...